SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-24-001676
Filing Date
2024-03-25
Accepted
2024-03-25 17:12:43
Documents
55
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 coeptis_i10qa-033123.htm   iXBRL 10-Q/A 1225696
2 CERTIFICATION coeptis_ex3101.htm EX-31.1 8515
3 CERTIFICATION coeptis_ex3102.htm EX-31.2 8427
4 CERTIFICATION coeptis_ex3201.htm EX-32.1 2518
5 CERTIFICATION coeptis_ex3202.htm EX-32.2 2261
  Complete submission text file 0001683168-24-001676.txt   7288782

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE coep-20230331.xsd EX-101.SCH 42419
7 XBRL CALCULATION FILE coep-20230331_cal.xml EX-101.CAL 45583
8 XBRL DEFINITION FILE coep-20230331_def.xml EX-101.DEF 214336
9 XBRL LABEL FILE coep-20230331_lab.xml EX-101.LAB 292652
10 XBRL PRESENTATION FILE coep-20230331_pre.xml EX-101.PRE 253277
58 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10qa-033123_htm.xml XML 1627534
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39669 | Film No.: 24780121
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)